Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction

NCT02292043 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2014-11-17

No results posted yet for this study

Summary

The investigators would evaluate the effects of the novel method, HTEA on cardiac function in the heart failure patients secondary to idiopathic dilated cardiomyopathy and post-myocardial infarction.

Conditions

  • Congestive Heart Failure

Interventions

DRUG

HTEA

HTEA

Sponsors & Collaborators

  • Harbin Medical University

    lead OTHER

Principal Investigators

  • wei liu · First Affiliated Hospital of Harbin Medical University

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02292043 on ClinicalTrials.gov